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INTRODUCTION
Carcinoma  Cervix  is  the  second  most  common  cancer  worldwide  especially  in 
perimenopausal  period.  In  developing  countries  like  Asia,  Africa  and  South  America  it  is  the 
commonest malignancy largely due to lower socioeconomic status, poor hygiene, illiteracy and 
paucity of screening programs.(14,15,51)
Pre – Cancerous lesions precedes a majority of cervical carcinoma and may exist in the non 
invasive stage for longer periods and shed abnormal cells which can be detected by exfoliative 
cytology  using  papanicoloau  stain  (2,14,15). Papanicoloau  smears  remain  a  simple  screening 
method for detecting the precancerous lesions of cervix inspite of limitations due to sampling and 
preparation errors. With effectiveness of Papanicoloau cytological test and the accessibility of the 
cervix by colposcopic examination and biopsy, the detection rate of precancerous lesions have 
improved.
In  invasive  carcinoma  of  cervix,  which  are  largely  detected  by  biopsies,  cancer  cell  
proliferation  greatly  influences  the  clinical  out  come  of  the  patients.  The  available  evidences 
indicate that evaluation of cell kinetic parameters may help surgical Pathologists and Oncologist to 
define the biological behaviors of cancer.
A variety of tests are available for the assessment of cellular proliferative activity. Mitosis 
count  has been the traditional  method,  however  it  detects  only major  differences and can be 
technically  difficult  and  time  consuming.  With  flow cytometry,  the  percentage  of  dividing  cells  
calculated as the S-Phase fraction. The main disadvantage is that specimen is destroyed in the 
process, thus cellular subpopulations within the tumour or admixtures of normal cells cannot be 
evaluated.  Immunohistochemical  methods  for  cell  proliferation  markers  like  Ki  –  67,  PCNA 
(Proliferating Cell Nuclear Antigen), DNA polymerases can be used, but they are more complicated 
and expensive than the silver stain used to show Nucleolar Organizing regions.(13,15)
A significant correlation between the interphase AgNOR (Argyrophilic Nucleolar Organizer 
Regions) quantity and prognosis has been reported in many neoplasms like Carcinoma breast,  
Lung,  Gastrointestinal  tract,  and  hematological  malignancies  (1,3,4,5,6,7,8,13,30).  There  was  A 
CLOSE  CORRELATION  BETWEEN  THE  PROLIFERATIVE  BEHAVIORS  AND  THE 
QUANTITATIVE  AND  QUALITATIVE  CHANGE  OF  AgNOR  (SILVER  STAINED  NUCLEOLAR 
ORGANIZER REGIONS) WAS FOUND IN OBVIOUSLY MALIGNANT NEOPLASMS.
There  are  also  many  studies  using  AgNOR  conducted  in  preinvasive  and  invasive 
squamous epithelial lesions of cervix and AgNOR(20,22,2,3,24,27,28,31,32,34,46,48,51,52,54) proved to 
be a simple inexpensive and reliable proliferation marker in lesions of cervix.
Radiotherapy, which is the main mode of treatment in Carcinoma Cervix. AgNOR proved to 
be a sensitive marker to predict the prognosis of the patient treated with radiotherapy. In a rural  
and  semi-urban  areas  where  sophisticated  methods  are  not  available,  AgNOR  COUNTS  IN 
CERVICAL SMEARS PROVE  TO  BE A SIMPLE AND COST EFFECTIVE  METHOD IN  THE 
DIAGNOSIS, PROGNOSIS AND FOLLOW UP OF CARCINOMA CERVIX PATIENTS.(16,21,26)
The QUANTITY OF INTERPHASE AgNOR (SILVER STAINED NUCLEOLAR ORGANIZER 
REGIONS)  IS  CONSIDERED  AS  A PARAMETER  OF  CELL KINETICS.  Nucleolar  Organizer 
Regions  (NOR)  are  components  of  ribosomal  DNA located  in  the  short  arms  of  acrocentric  
chromosomes of 13,14,15,21 and 22 and transcribe to ribosomal RNA. NOR’s vary in size and 
shape according to nucleolar transcription. They are intimately related to the cell cycle and may be 
RELATED TO PROLIFERATION AND PLOIDY.(1,7,18)
A prospective  study  of  Carcinoma  Cervix  with  AgNOR  is  undertaken  to  confirm  the 
diagnosis before radiation to access the prognosis at consecutive intervals of 4 – weeks and 8 - 
weeks with special attention to the Nucleolar changes. In addition, the recent literature regarding 
Carcinoma Cervix and value of AgNOR in diagnosis and treatment of Carcinoma Cervix is also 
reviewed.
AIM OF THE STUDY
1) To evaluate the incidence and prevalence of Carcinoma Cervix.
2) To assess the value of AgNOR IN CERVICAL CANCERS AS WELL AS IN   
      CONTROL.
3) To assess the AgNOR SENSITIVITY ACCORDING TO DIFFERENTIATION  
      AND MORPHOLOGICAL CHARACTERIZATION.
4) To assess the PROLIFERATIVE ACTIVITY OF NEOPLASTIC CELLS AND 
      IT’S PROGNOSIS.
5) To evaluate the TREATMENT RESPONSE WITH PRE AND POST   
      EXTERNAL BEAM  RADIATION IN CERVICAL CANCER.
MATERIALS AND METHODS
This  study  includes  50  Carcinoma  Cervix  patients  referred  from  RAJA MIRASUDAR 
HOSPITAL which is affiliated to THANJAVUR MEDICAL COLLEGE, THANJAVUR during the two 
year period from JUNE 2004 to JUNE 2006 and 25 cases served as control.
A detailed clinical history like age, parity, age at menarche, years of married life, years after  
last  delivery,  hematological  investigations,  review  of  previous  cytology  and  histopathological  
examination, family status/ socio economic status was done in all cases.
Cervical and Vaginal smears were collected from controls and from each patient prior to 
radiation therapy, using Wooden Ayres Spatula. By putting the woman on the examination table in 
dorsal position speculum was introduced into the vagina exposing the cervix and Wooden Ayres 
Spatula was introduced in to the posterior fornix. The Scraped material obtained was then spread 
on a slide. The pointed end of the Ayres Spatula was introduced into the cervical OS and rotated  
360°, sampling the whole ectocervix. For each patient two slides were taken and they were fixed 
immediately with isopropyl alcohol.
The cyto brush was also used in those patients to whom it is difficult to get endocervical  
samples and those who have stenotic cervical OS especially in post menopausal women. A cyto  
brush was introduced into the cervical OS till few bristles were seen outside the cervical OS. The 
brush was rotated 180° and then the brush was rolled over on a glass slide and specimen was 
fixed immediately.
The Cervical and Vaginal smears collected from controls and from patients prior to radiation 
therapy were subjected to AgNOR staining.
TECHNIQUE:
Single step AgNOR staining technique was employed for the demonstration of AgNOR’s 
(APPENDIX – 1). The freshly prepared solution was poured on to the smears which were then left  
in dark at 37°c for 30 minutes. Slides were dehydrated in 3 changes of acetone, cleared in Xylene 
and mounted in DPX.
The patients were given 40 – 50 gray of cobalt – 60 teletherapy divided in 20 – 25 fraction 
with daily fractions of 1.8 to 2.0 gray with five fractions per week.
In ideal patients, who respond to radiotherapy, as the tumor shrinks making the introduction 
of the uterine and vaginal applicators easy, the rest of the dose is delivered by brachytherapy by 
referring the patients to other higher centers.
The patients were followed and Cervical and Vaginal Smears were collected at intervals of 4 
and 8 weeks after completion of radiotherapy. AgNOR counting was carried out as proposed by 
Chiu et all (5).
REVIEW   OF LITERATURE  
INVASIVE CARCINOMA OF CERVIX:
The cervix is the commonest site for female genital tract cancer; statistics vary considerably 
from country to  country and from race to  race.  So in  African and Asian women living in poor 
conditions, the incidence and relative mortality rate of the carcinoma cervix is 4-5 times higher than 
those seen in developed countries.(14,15,51)
AEITOLOGY:
Age: Although invasive cancer of cervix is reported at all ages, it has two peaks, one at about 35  
yrs and another at 50-55 years, following which there is reduced incidence.(14,15,35,39)
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Cervical Intra epithelial Neoplasia (CIN) occurs at a much lower age. One third of the cases 
being found in women less than 30 years old.(2,16)
Religion and Race:
The women of Orthodox Jews and in Muslims, the incidence of cervical cancer is less due 
to ritual circumcision done in Male Children at the childhood. Certain races it is unusually common, 
for example Africans they are susceptible even if they live in conditions of squalor.
Social and Economic Factors:
The people living in low Socio economic status are more prone to cervical carcinoma. The 
possible operating factors are low standards of cleanliness (including penile hygiene), coitus at an 
early stage, and frequency of sexual intercourse and promiscuity of both partners.
Coitus:
The  sexually  active  women  are  4-5  times  more  likely  to  develop  cancer  than  sexually 
inactive women. It is postulated that smegma and spermatozoa are themselves carcinogenic.
Cervical Infection:
Human papilloma virus plays an important role in virtually all cases. 
15-20  types  of  HPV have  been  associated  with  cervical  carcinoma,  type  16,  18,  31  and  45 
accounts for 80% of cervical carcinoma. HPV 16 is associated with 50% of cases. (14,15,35,44)
 Hormonal Factors:
There  is  some  evidence  that  Oestrogen  -  Progesterone  Oral  Contraceptive  pill  usage 
favours CIN changes and also for Adeno carcinoma.
Predisposing Histological Status:
Certain histological changes in the cervix which are alleged to be “Pre cancerous” or which 
are sometimes confused with cancer include basal oell hyperplasia, squamous cell metaplasia and 
CIN. Of these, only CIN II-III are likely to significant forerunners of invasive carcinoma.(26,50)
Histological Classification of Cancer Cervix:
Carcinoma cervix nearly always starts at the squamo-columnar epithelial junction and 80-
90% cases are squamous cell in type.
In  5-10%  of  cases  it  is  entirely  columnar  cell  in  pattern  (AdenoCarcinoma)  and  the 
frequency is increasing especially in young women who are smokers or pill-users. The remainder 
constitutes the mixed types.
WHO Histological Classification Of Tumors Of The Uterine Cervix 
Epithelial Tumors
Squamous tumors and precursors
Squamous cell carcinoma, not otherwise specified
Keratinizing
Non – Keratinizing
Basaloid
Verrucous
Warty
Papillary
Lymphoepithelioma –like
Squamotransitional
Early invasive (micro invasive) squamous cell carcinoma
Squamous intraepithelial neoplasia
Cervical intraepithelial neoplasia (CIN) 3 /
Squamous cell carcinoma in situ
Benign squamous cell lesions
Condyloma acuminatum
Squamous papilloma
Fibroepithelial polyp
Glandular tumors and precursors
Adenocarcinoma
Mucinous adenocarcinoma
Endocervical
Intestinal
Signet-ring cell
Minimal deviation
Villoglandular
Endometrioid adenocarcinoma
Clear cell adenocarcinoma
Serous adenocarcinoma
Mesonephric adenocarcinoma
Early invasive adenocarcinoma
Adenocarcinoma in situ
Glandular dysplasia
Benign glandular lesions
Müllerian papilloma
Endocervical polyp
Other epithelial tumors
Adenosquamous carcinoma
Glassy cell carcinoma variant
Adenoid cystic carcinoma
Adenoid basal carcinoma
Neuroendocrine tumors
Carcinoid
Atypical carcionoid
Small cell carcinoma
Large cell neuroendocrine carcinoma
Undifferentiated carcinoma
Mesenchymal tumors and tumor – like conditions
Leiomyosarcoma
Endometrioid stromal sarcoma, low grade
Undifferentiated endocervical sarcoma
Sarcoma botryoides
Alveolar soft part sarcoma
Angiosarcoma
Malignant peripheral nerve sheath tumor
Leiomyoma
Genital rhabdomyoma
Postoperative spindle cell nodule
Mixed epithelial and mesenchymal tumors
Carcinosarcoma (malignant müllerian mixed tumors, metaplastic carcinoma)
Adenosarcoma
Wilms tumor
Adenofibroma
Adenomyoma
Melanocytic tumors
Malignant melanoma
Blue naevus
Miscellaneous tumors
Tumors of germ cell type
Yolk sac tumor
Dermoid cyst
Mature cystic teratoma
Lymphoid and haematopoetic tumors
Malignant lymphoma (specify type)
Leukaemia (specify type)
Secondary tumors
Reagan et al (1957) recognized three groups of squamous cell carcinoma
φ Large cell Keratinizing type
φ Large cell Non – Keratinizing type
φ Small cell Non – Keratinizing type
and other categories have been adopted by World Health Organization (Ritton & Christopherson 
1973).
Cervical Intraepithelial Neoplasia:
This is an intraepithelial  neoplasia that encompasses a continuum of morphologic 
changes arising in the basal layer of the stratified squamous epithelium of the transformation zone 
and extending to the entire thickness of the epithelium. The progression is divided into CIN I,II, and 
CIN III. Almost 60% of CIN I and 50% of CIN II lesions regress spontaneously. The remainder  
either persists or progresses through intermediate stages to invasive cancer. The majority of CIN III 
lesions progress to  invasive  cancer  over  10-20 years.  The majority  of  high-grade lesions are 
associated with HPV-16, 18, 31 and 33.(14,15,35)
Symptoms and Signs:
In  its  early  stage,  invasive  carcinoma  causes  no  symptoms  and  is  discovered 
accidentally. Irregular  uterine  bleeding,  post  coital  bleeding,  foul  smelling  discharge  with  an 
offensive odour are present in most cases.
On examination per vaginum cervix shows indurations, irregularity and easily bleeds 
on touch.
Diagnosis: 
Screening for prevention of cervical cancer
Cervical cytology with Papanicoloau Staining (APPENDIX 2) has been the mainstay 
of screening. The most effective method of obtaining a specimen is to use a cytobrush for the  
endocervical canal and scraping the ecto cervix with an Ayres spatula.(25,49)
Cytological screening has been established in most developed countries resulting in 
marked decrease in incidence of invasive cervical cancer.
The pre invasive-stage can be detected by the cervical smear test, which is simple, 
safe, in expensive and generally acceptable to women. All sexually active women are at risk and 
should be screened every year.
Cytological terminology of Cervical Precancer:
Papanicoloau’s Classification was used for many years and his classification I to V 
have been adhered to until recently by some cytologists and gynecologists.(2,25,49)
Class I - Negative -   Absence of atypical / abnormal cells
Class II - Negative -   Atypical cells present but without 
    abnormal features
Class III - Suspicious -   Cells with abnormal features suggestive               
                                                          but not conclusive for malignancy
Class IV - Positive -   Cells and cell clusters fairly conclusive for  
                                                          malignancy
Class V - Positive -   Cells and cell clusters conclusive for 
    Malignancy
WHO Classification:
Ritton and Christopherson used conventional histological terminology of mild, moderate and 
severe dysplasia and carcinoma in situ, as well as atypical metaplasia.
British Society for Clinical Cytology Terminology (BSCC):
BSCC’s first working party on terminaly recommended the term dyskaryosis 
Cytology Expected histology
Mild dyskaryosis CIN I    (Mild dysplasia)
Moderate dyskaryosis CIN II   (Moderate dysplasia)
Severe dyskaryosis CIN III  (Severe dysplasia)
Bethesda System:
The  1988  Bethesda  system  for  reporting  cervical  /  vaginal  cytologic  diagnosis  was 
published. The workshop agreed that the Papanicoloau classification was no longer appropriate 
and proposed the three essential components of cervical / vaginal smear report.(2,25,49)
The 1991 Bethesda System for Reporting cervical / vaginal cytologic diagnosis:
A) Statement of adequacy of the specimen
a) Satisfactory for evaluation when the specimen has correct   
    identification with a minimum of pertinent clinical information and the  
    smears contain an adequate number of well preserved and well  
    visualized epithelial cells, including endocervical.
b) Satisfactory for evaluation but limited-by lack of pertinent clinical data  
    or smears have an excess of blood, inflammatory cells, contaminants  
    or are poorly fixed with air drying artifacts etc or contain no adequate   
    endocervical or transformation zone cells. 
c) Unsatisfactory for evaluation (Specify reason)
B) General Categorization: 
                         (Optional, used to facilitate the triage of the specimens)
a) Within normal limits
b) Benign cellular changes: see descriptive diagnosis
c) Epithelial cell abnormality: See descriptive diagnosis
C) Descriptive Diagnosis:
a) Benign Cellular Diagnosis
1) Infection with organisms morphologically consistent with  
Trichomonas Vaginalis.
2) Fungal organisms consistent with candida species
3) Predominance of coccobacilli consistent with shift in vaginal flora
4) Bacteria consistent with Actinomyces sp.
5) Cellular changes associated with herpes simplex virus
6) others
b) Reactive changes associated with
1) Inflammation (includes typical repair)
2) Atrophy with inflammation (“atrophic vaginitis”)
3) Radiation and chemotherapy effect
4) Intra uterine contraceptive device
5) Other
c) Epithelial cell abnormalities
I) Squamous cell
a) Atypical squamous cells of undetermined     
   Significance qualify (AGUS)
b) Low grade squamous intraepithelial lesion (SIL)  
    encampassing changes of HPV and CIN I
c) High grade squamous intraepithelial lesion (SIL)    
   encompassing changes of CIN II and CIN III
d) Squamous cell carcinoma
d) Glandular cell
1) Endo metrial cells cytologically benign in a post meno pausal  
    Woman
2) Atypical glandular cells of uncertain significance qualify
3) Endocervical adenocarcinoma
4) Endometrial adenocarcinoma
5) Extra uterine adenocarcinoma
6) Adenocarcinoma NOS
The Bethesda System includes a new term Squamous Intraepithelial Lesion (SIL) which is  
divided into two grades. Low grade SIL to include HPV and CIN I and High grade SIL for cells from 
CIN II and CIN III.
This division of precancerous lesions of the squamous epithelium into two grades instead of  
three is intended to improve reproducibility of reports of abnormal cervical cytology and to relate  
classification to the management of the patient. High grade SIL is an indication for excision or 
ablation of the abnormal tissue, whereas Low grade SIL may be followed up initially by cervical  
cytology alone.
Comparison  of  terminologies  used  for  abnormal  squamous  epithelial  cells  in  cervical 
cytology:
CIN Grade WHO BSCC Bethesda
Borderline Atypia (ASCUS)
I Mild dysplasia Mild dyskaryosis Low grade SIL
II Moderate dysplasia Moderate dyskaryosis High grade SIL
III Severe dysplasia
Carcinoma in Situ
Severe dyskaryosis High grade SIL
Epidemoid Ca Severe dyskaryosis Squamous Carcinoma
? invasive carcinoma
The Cytology of CIN and invasive squamous cell carcinoma Dyskaryosis
The term dyskaryosis means literally “abnormal nucleus”. The morphological abnormalities 
seen in the nucleus of epithelial cells in cervical smears include a combination of any number of 
the following.
1) Disproportionate nuclear enlargement
2) Hyperchromasia
3) Bi and Multinucleation
4) Irregularity in form and outline
5) Abnormal chromatin pattern appearing as coarsening, stippling, formation of clumps or 
strands  and  sometimes  as  condensation  beneath  the  nuclear  membrane  producing 
apparent irregularities in its thickness
6) Abnormalities of the number, size and form of nucleoli
1) Cytological findings of Mild Dyskaryosis / CIN I
 Disproportionate nuclear enlargement, the nucleus usually occupy less than half 
the area of the cell
 Nuclear hyperchromasia
 Abnormal nuclear pattern
 Irregularity of the nuclear membrane
 Multiple abnormal nuclei
 Cytoplasm reduced and usually thin
 Cell borders are usually angular
2) Cytological findings of Moderate Dyskaryosis / CIN II
φ Disproportionate nuclear enlargement, the nucleus usually occupying between 
one half and two thirds of the total area of the cell
φ Abnormal chromatin pattern, often more marked than in mild dyskaryosis
φ Irregular nuclear membrane
φ    Nuclear hyperchromasia
φ Multiple abnormal nuclei
φ Cytoplasm reduced, may be thick or thin
φ Cell borders may be angular / rounded
3) Cytological findings of Severe Dyskaryosis and CIN III
o Disproportionate nuclear enlargement with the nucleus 
usually occupying at least two thirds of total area of the cell
o Abnormal chromatin pattern
o Nuclear hyperchromasia
o Irregularity of nuclear membrane
o Multiple abnormal nuclei
o Cytoplasm  markedly  reduced  abnormal  maturation  of  cytoplasm    including 
Keratinization
o Cell borders smooth or angular
o Nucleoli prominent when CIN III is wide spread
o Bizarrely shaped cells sometimes including fibre cells
4) Micro invasive and Invasive Squamous Cell Carcinoma
Cytological features of invasive carcinoma:
Most cytologic specimens are obtained by direct scraping of the lesion. The most 
important  sampling  error  that  may lead  to  false  negative  interpretation  is  when  the  clinicians 
scrapes the bottom of the ulceration rather than its margins which will contain only debris, blood  
and inflammatory cells, mixed with a few hard to recognize degenerated cancer cells.
Well Differentiated (Keratinizing) Squamous Cell Carcinoma
They make up to 20% of invasive cervical squamous cell carcinoma
Cellular Morphology:
-The cancer cells shed singly and in clusters (55%) sheets (30%), or    
  malignant pearl (2%) or in synticial form (13%)
-The shape of the cell is very pleomorphic which may be polygonal  
  (55%), flat, round (10%), tadpole (10%), spindle (5%), irregular or  
   pearl formation (10%)
-The size of the nuclei ranges from 2-10 times the size of normal   
  squamous cells. The shape is round (30%), oval (20%) or irregular    
  (40%) and varies with the shape of the entire cell (elongated) in  
  spindle cells and round, irregular in polygonal cells 
-The cytoplasm shows keratin deposition (40%) in concentric,  
   perinuclear, ring like formations
-Background of the smear shows a large number of nonspecific  
   Inflammatory cells and cellular debris (Tumor diathesis)
Moderately differentiated (Nonkeratinizing large cells carcinoma)
70 % of the cervical cancers are of this type 
Cellular Morphology:
o The  numerous  diagnostic  cells  are  large  either  single  (70%)  or  syncytial 
formation (30%). Epithelial  sheets and pearl  formations are absent.   The cells 
vary in shape (round to polygonal)
o The cytoplasm is usually basophilic varies in amount and contain little mature 
keratin
o The  nuclei  are  round  or  oval  and  less  irregular,  chromatin  is  coarse  and 
irregularly clumped
o The eosinophilic nucleoli are often larger and more prominent than seen in 
well differentiated cancer cells
o The background of the smear shows severe tumor diathesis, containing large 
amounts of degenerate cellular debris red blood cells and protein deposits
Poorly differentiated squamous cell carcinoma
Based on their cellular morphology and ultra structures, some of
these cancers are thought to be Neuroendocrine origin. They are often located toward the 
endocervical canal and represent 7% of invasive cervical carcinoma.
Cellular Morphology:
An abundance of diagnostic cells (>1000) usually found in the smear, which are usually 
single diagnostic cells. 
The cells vary moderately in size and shape and are usually either  round or  oval.  The  
delicately vacuolated cytoplasm of these cells is basophilic (80%), scanty and often seen as a  
narrow rim. Because of the fragility of this cytoplasm large number of “naked” malignant nuclei are 
usually present in the smear.
The nuclei are angular / oval shaped, with irregular chromatin clumps, multi nucleation is 
common. In clusters, the cells may overlap, with intercellular or slit like spaces.
- Pseudo cannabalism (birds eye appearance) is common
- Severe tumor diathesis is seen
HISTOLOGY:
 In Micro invasive carcinoma, usually displays extensive CIN III, from which tongues 
and islands of neoplastic cells extend through the basement membrane in a spray like pattern of 
later as confluent invasion.
Well  Differentiated Squamous Cell  Carcinoma includes the presence of  large islands of 
infiltrating  tumor  cells  with  intercellular  bridges,  epithelial  pearl  formation  and  obvious 
kernatinization of the cell cyto plasm.
Moderately Differentiated Squamous Cell Carcinoma show some evidence of a squamous 
origin,  consisting  of  solid  islands  and  smaller  groups  of  polygonal  pleomorphic  cells,  but 
kertinization and intercellular bridges are less obvious and pearl formation is not seen.
Poorly Differentiated Squamous Cell Carcinoma invades as sheets, islands and single cells 
often invoking a pronounced inflammatory reaction. No definite squamous features are seen and 
their origin may only be established with special stains to exclude mucin production and IHC for  
keratin expression with monoclonal antibodies.(14,15,35)
The Nucleolar Organizer Regions – A Review
Nucleolar Organizer Regions (NOR’s) are DNA loops transcribing to
ribosomal  RNA’s.  In  the  human  karyotype,  NOR  are  secondary  constrictions  of  metaphase 
chromosomes and are located in the short arms of the acrocentric chromosomes 13,14,15,21 and 
22. In chromosome preparations, NOR can be clearly visualized using In Situ hybridization or by 
ammoniacal  or  formic  acid  silver  nitrate  staining.  The silver  stainability  or  NOR is  due to  the 
presence of a peculiar set of acidic proteins, which are highly argyrophilic.(3,37,38)
Structure and Function of Interphase NOR
The nucleolus is a well defined structural, functional domain of the cell nucleolus in which 
ribosomal genes are located and ribosomal biogenesis occurs. Mammalian cell nucleoli constantly 
exhibit apart from intranuclear chromatin, three main components.
1) The Fibrillar Centers, which appear as rounded structures of different size composed of  
very thin loosely, inter oven fibrils.
2) The Dense Fibrillar Component frequently located at the periphery of the fibrillar centers, 
which is composed of densely packed fibrils.
3) The Granular component composed of granules surrounding the fibrillar components.
The  fibrillar  centers  plus  the  closely  associated  dense  fibrillar  component  have  been 
identified as the inter phase counterparts of metaphase NOR.(37,38)
Interphase  NOR  can  be  considered  to  represent  structural-functional  units  for  rRNA 
transcription.  The  two  main  enzymes  controlling  transcription  RNA  polymerase  I  and 
topoisomerase I have been clearly localized in the interphase NOR by ultra structural and immuno 
cytochemical investigations. The AgNOR proteins play a fundamental role in the control of rRNA 
transcription and processing. The two main proteins are called Protein C23 or Nucleolin (105kda) 
and protein B23 or Numatrin or Nucleophosmin (39kda).
Interphase NOR and Nucleolar Pathology:
The size and shape of the nucleoli is highly variable from cell to cell and in the same type of  
cell from the resting to proliferative state. Ultrastructural studies have shown that this variability is 
due to different distribution of the nucleolar components. A solitary large fibrillar center surrounded 
by a rim of ribonucleoprotein characterizes the very small nucleoli of resting lymphocytes. Whereas 
numerous small fibrillar centers, each surrounded by a rim of dense fibrillar component frequently 
intermingled with  granules  is  characteristic  of  large nucleoli  of  phytohaemagglutinin  stimulated 
lymphocytes.(37,38)
Until  recently,  a  precise  evaluation  of  nucleolar  morphology,  and its  change during  cell 
activation or transformation was impossible to be performed in routine cytopathology and histology 
at light microscopial level. Small nucleoli are frequently undetected and large nucleoli, independent 
of their size and shape are generally defined as “Prominent”.
In 1986, Ploton and co-worker applying the formic acid silver nitrate staining method for  
AgNOR  proteins  at  the  light  microscopy  level,  succeeded  in  a  very  precise  visualization  of 
interphase NOR. By means of this procedure interphase NOR appear as well defined black dots  
evaluated by light microscopy, and each dot correspond to one interphase NOR as visualized by 
the electron microscope.(37,38)
How can Interphase AgNOR be quantified?
The method more  frequently employed consisted  of  counting the  number  of  interphase 
AgNOR per  cell,  evaluating  the  sample  directly  at  the  light  microscope  by  carefully  focusing 
throughout the section thickness at very high magnification (100 x oil immersion level) (5,7,8).
Though it is time consuming and subjective errors do occurs, the drawbacks are eliminated 
by the morphometric evaluation of the area of interphase AgNOR using a computer assisted image 
analyses.
Interphase AgNOR and Diagnosis of Malignancy:
Ploton and co-workers have demonstrated that malignant cells have a greater quantity of 
interphase AgNOR than the corresponding benign or  normal  cells  and therefore  evaluation of 
interphase AgNOR distribution may be useful for the diagnosis of malignancy.(37,38)
According  to  Crocker,  interphase  AgNOR quantity  can  be  recommended  as  a  suitable 
parameter for diagnosis of malignancy only in a few type of cancers. AgNOR values were found to  
be  useful  in  differentiating  Nevo  cellular  nevi  and  malignant  melanoma,  between  infiltrating 
lymphocytes and Oat cell carcinoma deposits in bronchial material, between reactive mesothelial 
proliferation  and mesothelioma,  normal  cirrhotic  and carcinomatous liver,  between benign and 
malignant salivary gland tumors and between low grade and high grade Non Hodgkins Lymphoma .
(6,7,8)
Therefore AgNOR quantify can be considered only as one, among the other well established 
cyto-histopathological parameters to be used for diagnosis of malignancy.
Nevertheless, it is incontestable that in a broad sense, the quantify of interphase AgNOR is 
greater in cancer than in normal or hyperplastic cells.
Why do Cancer Cells have a large number of interphase AgNOR?
Considering the central role of interphase AgNOR in rRNA synthesis, changes of interphase 
NOR distribution in cancer cells might be the consequence of the increased demand for ribosomal 
biogenesis which characterizes dividing cells.
In  cells  stimulated  to  proliferate,  concurrently  with  an  increased  synthesis  of  AgNOR 
proteins, a progressive dispersal of ribosomal chromatin has been described, whereas in resting 
cells ribosomal sequences are located in highly compact structured chromatin.
INTERPHASE AgNOR AND CANCER PROGNOSIS
The data reported above concerning the relationship between interphase AgNOR and 
cell proliferation clearly indicate that the quantity of interphase AgNOR’s can be considered as a 
parameter of cell kinetics. The greater the interphase AgNOR amount, the shorter the cell doubling 
time.(2,9,14)
The cell kinetic parameters may help pathologists and clinical oncologists to define 
the biological behaviors of cancer lesions, obtain valuable prognostic information and indications 
about specific treatments of cancer.
Neverthless, a significant correlation between interphase AgNOR quantity and patient 
survival has been reported in many types of neoplastic diseases.(34,41) In two types of cancer 
lesions interphase AgNOR evaluation has been proved to be of great importance.
1) Patients with lower number of interphase AgNOR in colorectal     
    cancers still alive after 5 years, than those who presented  
    with higher counts.
2) In stage I endometrical carcinoma, 10 year follow up study  
    showed that 90% of patients with low interphase AgNOR  
    values were still alive, whereas 60% of patients with high   
    interphase AgNOR values died of the disease.
Multivariate analysis of survival in both these cancers demonstrated that quantity of  
AgNOR represented  the  most  important  prognostic  parameter  when  compared  to  histological 
grade.
Interphase  AgNOR  quantification  appears  to  be  very  interesting  and  promising 
method for the routine evaluation of cell  kinetics for prognostic purposes. It is the only method 
which permits information to be obtained on the rapidity of cell proliferation in routinely processed 
samples.  Only  flow cytometry,  by  simultaneous  analysis  of  DNA content  and  incorporation  of  
injected bromo deoxyuridine in vivo, permits measurement of cell doubling time.
Interphase  AgNOR  staining  is  not  expensive  and  very  rapidly  executed  on  the 
cytological  smear and tissue sections.  Moreover  AgNOR distribution in  cancer  tissues can be 
directly  perceived  at  light  microscopic  examination  without  using  additional  instruments  for 
objective AgNOR quantification.(34,39,41)
RADIATION FOR CERVICAL CANCERS: 
All  cervical  cancers,  except  stage  I  and  II  A are  primarily  treated  with  radiation 
therapy.  The chief  modalities  of  present  day radiation  treatment  of  cancer  cervix  are  external 
photon beam treatment and brachytherapy.
External Beam Radiotherapy ( EBRT ) (Teletherapy):
EBRT is used to treat the pelvic lymphnodes, commoniliac lymphnodes, Para-aortic nodes 
and lateral parametria. A dose of 45-50 gy is delivered by EBRT over five weeks, with daily fraction 
of 1.8 to 2 gy, five fractions per week. As the tumor shrinks making introduction of uterine and 
vaginal applicators easy, rest of the dose is delivered by brachytherapy.
Brachytherapy: 
 The word “Brachy” in Greek means “short distance”. It implies placing radioactive 
sources in contact with or very close to target tissue. The implants are classified into High Dose 
Rate (HDR) and Low Dose Rate (LDR).  Dose rates of 0.4 to 2 gy/hour are delivered in LDR 
brachytherapy so that the treatment time is 24-72 hours. In HDR brachytherapy implant uses dose 
rates > 12 gy/hour and the total dose can be delivered in few minutes.
Isotopes used in LDR brachytherapy are Cs137 (caesium) and for HDR brachytherapy 
Co60 (cobalt), Ir192 (Iridium) isotopes are used both for LDR and HDR therapy.(51)
OBSERVATION AND RESULTS
The  prospective  study  included  50  exfoliative  cytology  specimens  of  clinically 
evaluated and diagnosed cases of squamous cell Carcinoma of Cervix. This study also includes 25 
control specimens for comparison and correlation of efficacy of AgNOR in cervical cancers. The 
clinical, cytological feature, histopathological data and AgNOR study conducted in cases are listed 
in  the  master  chart.  Table-1 shows  the  incidence  of  cervical  cancers,  referred  for  cytological 
evaluation and subsequent confirmation by histopathological examination, during the period from 
JUNE 2004 TO JUNE 2006.
TABLE-1
Sl.No Period
Total No. of Pap 
smears
Positive cases
1
June 2004 – December 2004
280 10
2
January 2005 – June 2005
1201 15
3
July 2005 – December 2005
396 13
4
January 2006 – June 2006
286 12
Total 50
Table 1-A shows incidence of cervical cancers of biopsy /  gross specimens referred for 
histopathology evaluation after precytological evaluation (in proportion of cases).
TABLE 1-A
Sl.
No
Period Total No. of 
Gynaec 
Specimens
No. of 
Cervical
Biopsy
 for
cacx
Nonspecic 
changes
CIN 
change
Invasive squamous cell 
carcinoma
Well 
Diff
SCC
Mod.
Diff 
SCC
Poorly
Diff 
SCC
1 June 2004–
Dec 2004
934 205 31 29 42 101 2
2 Jan 2005 –
June 2005
807 214 86 22 14 100 2
3 July 2005 – 
Dec 2005
872 208 71 12 9 115 1
4 Jan 2006 – 
June 2006
779 207 60 26 16 104 1
               
                     TOTAL    =      3392 Total Invasive 
Carcinoma           =  507
AGE INCIDENCE:
The patients initially diagnosed with Papanicoloau Stain as Cervical Cancer were divided 
into 6 groups according to age (i.e., 20-30 yrs, 31-40 yrs, 41-50 yrs, 51-60 yrs, 61-70 yrs, and 71-
80 yrs). There was increased incidence of cervical cancer observed in the age group of 41-50 
years (38%) followed by 51-60 years (30%) and 31-40years (20%). 
The age distribution of cervical cancer is given in the following Table-2.
TABLE-2
Sl.No
Age Group No. of Cases Percentage
1 20 – 30 years 2 4
2 31 – 40 years 10 20
3 41 – 50 years 19 38
4 51 – 60 years 15 30
5 61 – 70 years 3 6
6 71 – 80 years 1 2
                      TOTAL  50 100
Most of the patients referred for Papanicoloau stain were belonging to surrounding villages 
of low socioeconomic status with poor hygiene and lived in over crowded surrounding. Most of 
them presented with foul smelling discharge / post coital bleeding, bleeding PV for which initial 
Papanicoloau cytological examination was undertaken.
In all 50 cases of initially diagnosed cervical cancers with cytology further cervical biopsies 
were undertaken and histopathological examination was done. 
The following Table-3 shows distribution of cervical cancers according to differentiation.
TABLE-3
Sl.No Grade No. of Cases Percentage
1 Well differentiated squamous 
cell carcinoma
9 18%
2 Moderately differentiated 
squamous cell carcinoma
37 74%
3 Poorly differentiated squamous
cell carcinoma
4 8%
In this study most of the cases are Moderately differentiated (37 cases, 74%), fig-2 followed 
by  Well  differentiated  squamous  cell  carcinoma  (9  cases,  18%) fig-1.  Poorly  differentiated 
carcinoma constitute only 8% of total cases fig-3.
The following Table-3A shows classification of cervical cancers (squamous cell carcinoma) 
according to morphological subtypes.
TABLE-3A
Sl.No Morphologic Subtype No. of Cases Percentage (%)
1 Non Keratinizing SCC 420 82.8
2 Keratinizing SCC 75 14.8
3 Small Cell SCC 6 1.2
4 Basaloid SCC 1 0.2
5 Verrucous SCC 1 0.2
6 Warty SCC 1 0.2
7 Papillary SCC 2 0.4
8 Lymphoepithelioma Like 1 0.2
In 507 cases of cervical cancers , most of the cases are Non Keratinizing SCC (420 cases), 
Keratinizing SCC (75 cases), Small cell (6 cases), Basaloid SCC 1 case) fig-4,4a, Verrucous SCC 
(1 case) fig-5,5a, Warty SCC (1 case) fig-6,6a, Papillary SCC(2 cases), Lymphoepithelioma Like 
(1  case) fig-7,7a were  referred  for  radiotherapy  of  which  50  cases  were  selected  for  our 
prospective study in which radiation was given and smears taken at 4 weeks and 8 weeks.
The Table-3B shows most of the cases are Non Keratinizing squamous cell carcinoma (35 
cases, 70%) followed by Keratinizing squamous cell carcinoma (8 cases, 16%). Small cell, non  
keratinizing  /  Poorly  differentiated  /  Neuro  endocrine  cancer  constitute  only  10%  (5  cases), 
Papillary squamous cell carcinoma 4% (2 cases) during the prospective study period.
TABLE- 3B
Sl.No Morphologic Subtype No. of Cases Percentage (%)
1 Non Keratinizing SCC 35 70
2 Keratinizing SCC 8 16
3 Small Cell SCC 5 10
4 Verrucous SCC - -
5 Warty SCC - -
6 Papillary SCC 2 4
7 Basolid SCC - -
8 Lymphoepithelioma Like - -
In this study 35 cases of Non Keratinizing squamous cell carcinoma, 8 cases of Keratinizing  
squamous cell  carcinoma, 5 cases of small  cell  Non Keratinizing squamous cell  carcinoma, 2 
cases of Papillary variant of squamous cell carcinomas were subjected for further management to 
radiotherapy.
Evaluation of AgNOR counts in controls and in cancer cervix, AgNOR size variation and 
distribution was recorded according to the criteria provided by Ashan et all. Students‘t’ test was  
applied for the statistical analysis of results.
Size variation was graded as follows
0 - More or less uniform size
1+ - Two different sizes
2+ - More than 2 different sizes (but not those of 3+)
3+ - All grades and sizes heterogenous
Distribution of AgNOR’s in the nucleoli were graded
0 - Limited to nucleoli
1+ - Occasional dispersion outside the nucleoli
2+ - Moderate dispersion outside the nucleoli
3+ - Widely dispersed throughout the nucleus
The  following  Table-4  shows  the  comparison  of  AgNOR  counts,  size  variation,  and 
distribution in control cases (25 cases) Fig-8.
 TABLE-4  
Sl.No Group AgNOR count / cell
AgNOR size
Variation
AgNOR 
distribution
Range Mean 0 - 1+ 2+ - 3+ 0 – 1+ 2+ - 3+
1 Control-25 
cases
1 – 3 1.63 22 3 23 2
22 cases exhibit size variation of 0 to 1+ and 3 cases shows 2+ to 3+ size variation. The  
AgNOR distribution is also 0 to 1+ in 23 cases and 2 cases shows 2+ to 3+. The AgNOR count per  
cell in all 25 cases ranged 1-3 AgNOR dots/cell, with mean of 1.63.
Similarly  the  comparison  was  done  in  50  cases  of  Carcinoma  Cervix  diagnosed  by 
histopathological examination prior to radiation as given in the following Table - 4A.
TABLE - 4A
Sl.No Grade AgNOR count AgNOR size variation AgNOR distribution
Range Mean 0 - 1+ 2+ - 3+ 0 - 1+ 2+ - 3+
1 Well
differentiated
SCC
3-8 3.76 2 7 1 8
2 Moderately 
differentiated 
SCC
3-5 3.84 3 34 2 35
3 Poorly 
differentiated
 SCC 
3-9 4.12 - 4 - 4
In well differentiated squamous cell carcinoma (9 cases), the AgNOR count/cell ranged from 
3-8 cell, with mean of 3.76, AgNOR size variation was 2+ to 3+ (7 cases), and 2 cases show 0 – 
1+, AgNOR distribution ranges 2+ - 3+ (8 cases), one case 0 - 1+. Fig-10
In  Moderately differentiated squamous cell  carcinoma (37 cases),  the AgNOR count/cell  
ranged 3-5/cell with mean of 3.84, AgNOR size variation was 2+ to 3+ in 34 cases and 2 cases  
show 0 to 1+, AgNOR distribution ranges 2+ to 3+ in 35 cases , two cases 0 to 1+. Fig-14
In Poorly differentiated squamous cell carcinoma (4 cases), the AgNOR count/cell ranged 
from 3-9/cell with mean of 4.12, AgNOR size variation and distribution ranged 2+ to 3+ in all four  
cases. Fig-18
Similarly comparison was done in 50 cases of carcinoma cervix, after 4 weeks of radiation 
as given in following Table -4B.
TABLE -4B
Sl.No Grade AgNOR count AgNOR size variation AgNOR distribution
Range Mean 0 - 1+ 2+ - 3+ 0 - 1+ 2+ - 3+
1 Well 
differentiated
SCC (9cases)
2-6 3.2 6 3 6 3
2 Moderately 
differentiated
SCC (37cases)
2-4 2.82 34 3 34 3
3 Poorly differentiated
SCC (4cases) 
2-5 3.35 2 2 2 2
In well differentiated squamous cell carcinoma (9 cases), the AgNOR count/cell ranged from 
2-6 cell, with mean of 3.2. AgNOR distribution ranges 0-1+ in  6 cases, 2+ - 3+ in 3 cases,  AgNOR 
size variation ranges from 0 – 1+ in 6 cases and 2+ to 3+ in 3 cases. Fig-11
In Moderately differentiated squamous cell carcinoma, the AgNOR count/cell ranged 2-4/cell 
with mean of 2.82, AgNOR size variation ranged 0 to 1+ in 34 cases, only 3 cases ranged 2+ to 3+, 
AgNOR distribution ranges 0 to 1+ in 34 cases and only 3 cases ranged 2+ to 3+. Fig-15
In Poorly differentiated squamous cell carcinoma (4 cases), the AgNOR count/cell ranged 
from 2-5/cell with mean of 3.35. AgNOR size variation ranged 0 – 1+ in 2 cases, 2+ to 3+ in 2 
cases. AgNOR distribution ranged 0 to 1+ in 2 cases and 2+ to 3+ in 2 cases. Fig-19
Similarly comparison was done in 50 cases of carcinoma cervix, after 8 weeks of radiation 
as given in Table -4C.
TABLE -4C
Sl.No Grade AgNOR count AgNOR size variation AgNOR distribution
Range Mean 0 - 1+ 2+ - 3+ 0 - 1+ 2+ - 3+
1 Well 
differentiated
SCC 
(9cases)
2-5 2.67 6 3 6 3
2 Moderately 
differentiated
SCC 
(37cases)
2-3 2.19 34 3 34 3
3 Poorly 
differentiated
SCC 
(4cases) 
2-4 2.97 2 2 2 2
In well differentiated squamous cell carcinoma (9 cases), the AgNOR count/cell ranged from 
2-5/cell with a mean of 2.67, the AgNOR size ranged 0 to 1+ in 6 cases, 2+ to 3+ in 3 cases. The 
AgNOR distribution ranged 0 to 1+ in 6 cases and 2+ to 3+ in 3 cases. Fig-12
In  Moderately differentiated squamous cell  carcinoma (37 cases),  the AgNOR count/cell  
ranged from 2 to 3/cell with mean of 2.19. AgNOR size variation and distribution ranged 0 to 1+ in  
34 cases, 3 cases ranged 2+ to 3+. Fig-16
In Poorly differentiated squamous cell carcinoma (4 cases), the AgNOR count/cell ranged 
from 2-4/cell with a mean of 2.97. AgNOR size variation and distribution ranged 0 to 1+ in 2 cases,  
2+ to 3+ in 2 cases. Fig-20
DISTRIBUTION OF AgNOR’S IN CARCINOMA CERVIX PRE AND POST RADIATION THERAPY 
(RT)
TABLE-5
Sl.No Category No. of Cases AgNOR Count/cellRange Mean
1 Control 25 1-3 1.63
2 Prior to RT 50 3-8 3.98
3 Post RT 
a) 4 weeks
      b)  8 weeks
50
50
2-5
2-4
2.92
2.43
4 Persistence of Malignancy 8 3-6 3.54
1:2 P< 0.001 1:3a P< 0.001 1:3b P< 0.001 1:4 P< 0.001
2:3a P< 0.001 2:3b P< 0.001 2:4 P> 0.05 3a:4 P< 0.001
3b:4 P< 0.001
AgNOR counts in control group ranged from 1-3 with a mean of 1.63. In all the 50  
cases of carcinoma cervix prior to radiation therapy the AgNOR counts ranged from 3-8 with a 
mean of 3.98,  significantly higher than that  in the control  group (P< 0.001).  After  irradiation a 
significant decline was noted in AgNOR counts which varied from 2-5 with a mean of 2.92 after 4 
weeks of irradiation and from 2-4 with a mean of 2.43 after 8 weeks of irradiation. The AgNOR 
score in 8 patients ranged from 3-6 (Mean 3.54) which is significantly higher (P<0.001) than the 
values obtained from the control group and from the patients who showed favourable response to 
radiotherapy consistent with persistence of malignancy Fig-21,22. The AgNOR counts observed 4 
and 8 weeks after radiotherapy compared shows significant reduction (P< 0.001) in the counts 
statistically. 
DISCUSSION
Carcinoma Cervix accounts for 80% of all  gynecological cancers including breast cancer 
being commonest cancer in women in the developing countries. The most common cancer among 
women in India is Cervical Cancer. The American cancer society estimates that 9,710 women will  
be diagnosed with and 3700 women will die of cancer of the cervix in 2006, however although 
globally, 5, 00,000 new cases of carcinoma cervix are recorded of which 1, 00,000 are from India .
(15,42)
In our prospective study the average incidence of cervical cancer in biopsy specimen is 
60.8% which is high when compared with studies conducted by various authors and literature.
Present Study Incidence 
TABLE -1A
Sl.
No
Period Total No. of 
Gynaec 
Specimens
No. of 
Cervical 
bx for 
cacx
Nonspecic 
changes
CIN 
change
Invasive squamous cell 
carcinoma
Well 
Diff 
SCC
Mod.
Diff 
SCC
Poorly 
Diff 
SCC
1 June 2004– 
Dec 2004
934 205 31 29 42 101 2
2 Jan 2005 – 
June 2005
807 214 86 22 14 100 2
3 July 2005 – 
Dec 2005
872 208 71 12 9 115 1
4 Jan 2006 – 
June 2006
779 207 60 26 16 104 1
               
                     TOTAL    =      3392 Total Invasive 
Carcinoma           =  507
The following Pie Chart shows the burden of cervical cancer all over the world.
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When considering the Age specific cancer incidence per 1, 00,000 population,  
the below bar chart shows that our study clearly shows increased ratio 51 / 1,00,000 
population well comparable to the incidence data of India/Madras and Indian and 
Chinese  people  living  in  Malaysia  and  is  well  compared  with  various  research 
workers as well as program like SEER (Surveillance Epidemiology and End Results) 
program.
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In India, carcinoma cervix continues to lead the list of cancers afflicting female 
genital tract because of poverty, poor socioeconomic status, wide spread ignorance, 
poor  personal  hygiene,  early  marriage  and  child  bearing  and  high  parity  status 
continue to prevail in our country. Religious taboos and social traditions instill a false 
sense of modesty which inhibits women, particularly from rural backgrounds from 
seeking medical aid for what they consider a minor gynecological problem.
The average age of women newly diagnosed with cervical cancer is between 
50 and 55 years (14,15,35,36,40). This cancer rarely occurs in girls younger than 15. It 
begins to appear in women in their twenties. Cervical cancer is different from most 
cancers that tend to occur more often as people get older. Although cervical cancer 
does  affect  young  women,  many  older  women  do  not  realize  that  their  risk  of 
developing cervical cancer does not go down as they age and that it is important for 
them to continue having Pap tests.
SEER Incidence:
From 2000-2003, the median age at diagnosis for cancer of the cervix uteri 
was 48 years of age. Approximately 0.1% were diagnosed under age 20. 15.4% 
between 20 and 34, 26.4% between 35 and 44, 23.3% between 45 and 54, 14.9% 
between 55 and 64, 10.4% between 65 and 74, 6.9% between 75 and 84, and 2.6% 
85+ years of age.(16,51)
The age adjusted incidence rate was 8.8 per  1,  00,000 women per  year. 
These  rates  are  based  on  cases  diagnosed  in  2000-2003  from  17  SEER 
(Surveillance Epidemiology and End Results) geographic areas. 
Incidence rates by race were
Race / Ethnicity Women
All Races 8.8 per 1,00,000 women
White 8.5 per 1,00,000 women
Black 11.5 per 1,00,000 women
Asian/Pacific Islands 8.2 per 1,00,000 women
American Indian/Alaska Native+ 7.2 per 1,00,000 women
Hispanic 14.2 per 1,00,000 women
In our study the youngest age group at which cervical cancer identified is 28 
and 29 years and incidence is common between 41-50 years followed by 51-60 
years(42,49). Our  study contrast  with  other  studies  that  the  initial  age of  cervical 
cancer is 5-10 years earlier than the western population.
Among the cervical carcinomas, 80% are in advanced stages, i.e., stage II B, 
III and IV and only 20% are in early stages i.e., in stage I and II A, while in UK 90% 
cases are in early stage and only 10% are in advanced stages.
TABLE -6        Patient Distribution According To Stage
Patients StageI B II A II B III A III B IV A
Study 
Burdwan 
Medical 
College
Number 
(292) 14 18 98 14 142 8
% 4.76 6.12 33.34 4.76 48.30 2.72
Present 
Study
Number 
(50) 5 8 29 1 2 5
% 10 16 58 2 4 10
The Table-6 shows that in our present study most of the patients are in
advanced stage as study conducted in Burdwan Medical College, Bengal, a rural 
teaching hospital. Stage II B and above constituted > 70% and < 30% were in stages 
of I B and II A which is well correlated. Most of the patients were coming for the first 
time  in  an  already  advanced  stage;  however  the  picture  is  reverse  in  western 
population, since females are evaluated consequently from the age of 18 years with 
Pap smears.
In our study above 74% of the cases are Moderately differentiated squamous 
cell  carcinoma followed by 18% Well differentiated carcinoma. This distribution is 
well  in  correlation  with  various  studies  that  Moderately  differentiated  infiltrating 
squamous cell carcinoma being the commonest type all over the world followed by 
Well  differentiated squamous cell  carcinoma when considering the morphological 
subtypes also, Nonkeratinising squamous cell carcinoma predominates (319 cases, 
88.12% in total cervical cancers, 35 cases, 70% in the present study).
In this study evaluation of Cervical Cancer with the AgNOR status is done 
with Pap smears after initial diagnosis with histopathological examination, 4 weeks 
after radiotherapy, as well as 8 weeks after radiotherapy cytological assessment has 
become a standard procedure for early detection of squamous cell carcinoma per 
se, and for assessment of radiation therapy changes and for AgNOR scoring.
The following  Table-7 shows AgNOR count/cell in squamous cell carcinoma 
cervix, a comparison with other study groups and present study.
TABLE-7
Sl.No Study Group
Grade of 
SCC
AgNOR Count/Cell
Range Mean
1 Ghazala Mehdi & Kafl Aktar
o Well
o Mod
o Poor
3.7–3.77
3.75-3.89
3.86-4.2
3.74
3.82
4.03
2 Jyotima Agarwal & J.K Gupta
o Well
o Mod
o Poor
5.27
5.41
5.37
3 Prathiba & Sarah Kuruvilla
o Well
o Poor
4.2
5.3
4
Seema Kashyap & Kusum 
Kapila
o Well
o Mod
o Poor
2.17-7.52
2.24-4.68
3.01-3.89
3.66
3.04
3.45 
5 Miller et al
o Well
o Poor
2.9
4.0
6 Present Study
o Well
o Mod
o Poor
3.76
3.84
4.12
Our  study  correlates  well  with  study  conducted  by  Ghalaza  Mehdi(18), 
Prathiba(39) and  Miller  et  al(29)  that  the  count  increases  when  the  neoplasm 
becomes well to poorly differentiated.
However in contrast Jyotima Agarwal(17) reported the AgNOR count is high in 
moderately differentiated squamous cell carcinoma followed by poorly differentiated 
squamous  cell  carcinoma.  Likewise  Seema  Kashyap  et  al(19,46) reported  high 
AgNOR count in well differentiated followed by poorly differentiated and moderately 
differentiated squamous cell carcinoma.
Rowland’s (1988) in a study of AgNOR in Cervical Intraepithelial Neoplasia 
did  not  give  any  significant  difference  in  AgNOR  counts  in  normal  squamous 
epithelium CIN I and CIN II, but there was a significant increase in CIN III group as 
well as invasive cancer(10,11).
Crocker et al who have done intensive work on NOR’s in various tumors have 
observed  three  main  types  of  AgNOR  configurations  in  normal  neoplastic 
cells(6,7,811,12). All three types of NOR patterns were observed in his study
 The  NOR’s  are  fully  aggregated  to  form  a  solitary  rounded 
structure, often seen in resting cell.
 Nucleolar  pattern  in  proliferating  cells,  where  NOR’s  can  be 
seen within the nucleolus
 Dispersion  of  small  NOR’s  throughout  the  nucleoplasm  as 
frequently observed in highly malignant cells.
Our study correlates with the other studies and literature that AgNOR count 
gradually increases from the normal to invasive cancer. In our study, the 25 control 
cases show an AgNOR count/cell of 1-3 with a mean of 1.63 and 3 cases exhibit a  
size variation of 2+ to 3+ and distribution variation of 2+ to 3+ in 2 cases. This may 
be reflected as initial SIL changes / Koilocytic changes / as a response to intense 
inflammatory reaction. 
These  cases  are  subjected  for  repeat  Pap  smears  at  3  month  intervals, 
revealed decreased in AgNOR counts to normal ratio at the end of one year.
With the standardization of the Silver staining technique diagnostic pathology 
has achieved a  new milestone.  The AgNOR’s  have  been shown to  reflect  DNA 
transcriptional activity. Study of AgNOR’s has been identified as a reliable indicator  
of cell proliferation and in turn of the malignant potential of a lesion. 
Malignant tumor cells are characterized by extremely large AgNOR’s which 
show a random or scattered distribution. They are useful in discriminating between 
benign and malignant conditions being significantly higher in malignant cells than in  
normal  cells.  They  also  serve  as  a  significant  prognostic  indicator  in  malignant 
lesions.
TABLE -8
Sl.No Grade Prior RT 
AgNOR 
count/cell
4 weeks after 
RT AgNOR
   count/cell
8 weeks after 
RT AgNOR 
count/cell
Range Mean Range Mean Range Mean
1 Well differentiated 
squamous cell 
carcinoma
3-8 3.76 2-6 3.2 2-5 2.67
2 Moderately 
differentiated 
squamous cell 
carcinoma
3-5 3.84 2-4 2.82 2-3 2.19
3 Poorly differentiated 
squamous cell 
carcinoma
3-9 4.12 2-5 3.35 2-4 2.97
The  Table-8 shows  in  our  prospective  study,  the  AgNOR  count/cell  has 
reduced from 3.76 to 3.2 and 2.67 (after 4 weeks and 8 weeks of radiotherapy in 
Well differentiated squamous cell carcinoma. However in Moderately differentiated 
squamous cell carcinoma the reduction is so impressive from a mean of 3.84 to 2.82 
to 2.19 (after 4 weeks and 8 weeks of Radiotherapy).
 Poorly differentiated squamous cell carcinoma also shows a reduction from 
4.12  to  3.35  and  2.97.  Our  study  correlates  well  with  Ghazala  Mehdi(30) that 
Moderately differentiated squamous cell carcinoma responds well with Radiotherapy 
followed  by  Well  differentiated  squamous  cell  carcinoma.  Poorly  differentiated 
squamous cell  carcinoma even though shows reduction  in  AgNOR range in  the 
mean, prior and post radiation, there is clear evidence that these cancers responds 
poorly to external radiotherapy alone, which suggests the use of internal as well as 
external  Radiotherapy  in  combination  in  cases  of  Poorly  as  well  as  Well 
differentiated squamous cell carcinoma.
In  our  study  8  cases  shows  persistence  of  malignancy after  8  weeks  of 
radiotherapy as given in the following Table-9.
TABLE-9
Sl.
No
Grade of 
Tumor
Persistence 
of 
malignancy 
No. of 
cases
Size 
of 
Tumor
Stage Anaemia 
Grade
Type of 
Radiotherapy
Disrupted 
Treatment
External
RT
Internal
RT
8 
wks
> 8 wks
1 Well 
Differentiated 
Squamous 
cell 
carcinoma
4 > 7cm
III B
III B
III A
IV A
+++
++
+++
+++
√
√
√
√
x
x
x
x
√
-
-
-
-
√
√
√
2 Moderately 
Differentiated 
Squamous 
cell 
carcinoma
2 > 6cm
IV A
IV A
+++
+++
√
√
x
x
-
√
√
-
3 Poorly 
Differentiated 
Squamous 
cell 
carcinoma
2 > 7cm
IV A
IV A
+++
+++
√
√
x
x
-
-
√
√
All cases with recurrence exhibit advanced stage at the time of presentation 
(>III  A /  III  B)  and  severely  anaemic,  all  cases  were  treated  only  with  external  
Radiotherapy and they did not stick on to the treatment modality.
CONCLUSION
In  the  present  prospective  study  comprising  of  50  Papanicoloau  cervical 
smears of carcinoma cervix and 25 controls suggest the following conclusions.
1. The incidence of cervical cancers in semi urban areas – Thanjavur is 
      51/1, 00,000 population.
2. Cervical cancers are common between the age group of 41-50 years which is in 
contrast low compared to western population where it is common in 51-60 years.
3. Squamous cell  carcinoma of  cervix constitutes  80% of  the gynecological 
cancers.
4. Most patients presents initially at an advanced stage (i.e., > II B).
5. Moderately differentiated squamous cell carcinoma is the commonest type 
observed as in other.
6. AgNOR technique provides an index of cell proliferation.
7. AgNOR count/cell increases gradually from normal to SIL changes to invasive 
carcinomas.
8. The AgNOR count is high in Poorly differentiated carcinomas and low in Well 
differentiated carcinomas.
9. Moderately  differentiated  squamous  cell  carcinoma responds  well  to  external 
radiotherapy alone.
10. Poorly differentiated squamous cell carcinoma requires both external and internal 
radiation for prognosis.
11. Viral induced changes can impart a slight increase in AgNOR count in normal 
individuals.
12. AgNOR study provides a  standard method to evaluate prognosis of 
the patient after radiotherapy.
The AgNOR technique which was used extensively in cytogenetics earlier, 
has now gained importance as an indicator of cell proliferation. In normal cells, the 
AgNOR  are  tightly  packed  in  the  nucleoli  and  are  indiscernible.  In  rapidly 
proliferating  neoplastic  cells  nucleolar  disaggregation  takes  place  resulting  in 
dispersion of individual AgNOR’s.
So  AgNOR count  is  a  reproducible, simple,  efficient  and  inexpensive 
method which can be used as an  adjunct to routine cytology for diagnosis of 
cervical carcinoma especially in doubtful cases and also used as a prognostic 
indicator.
APPENDIX-1
AgNOR STAINING
PREPARATION OF STAINING SOLUTION
Solution A: 2% gelatin in 100 ml of 1% Formic acid
Solution B: 50% aqueous silver nitrate solution in de-ionized water
WORKING SOLUTION
One part of Solution A mixed with two parts of Solution B
STAINING METHOD
The wet fixed cervical smears were exposed to freshly prepared working
solution for 30 min at 37°c, left in dark.
Slides were dehydrated in 3 changes of acetone, cleared in Xylene 
and
mounted in DPX.
APPENDIX-2
PAPANICOLAOU STAINING METHOD
7) Wet fixed smear, rinse in water for 1 min
8) Stain in Harris Haemotoxylin , 5 min
9) Rinse in water, 2 min
10)Differentiate in 0.5% aqueous hydrochloric acid, 10 seconds approx
11)Rinse in water , 2 min
12)“ BLUE “ in Scott’s tap water substitute, 2 min
13)Rinse in water, 2 min
14)Dehydrate, 70 percent alcohol for 2 min
15)Dehydrate, 95 percent alcohol for 2 min
16)Dehydrate, 95 percent alcohol for 2 min
17)Stain in OG 6, 2 min
18)Rinse in 95 percent alcohol, 2 min
19)Rinse in 95 percent alcohol, 2 min
20)Stain in EA 50, 3 min
21)Rinse in 95 percent alcohol, 1 min
From  
Theory and Practice of Histological Techniques, edited by John D Bancroft, 
Marilyn Gamble, 5th edition.
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